CN113891895A - 用于使用生物发光检测分析物的组合物和方法 - Google Patents

用于使用生物发光检测分析物的组合物和方法 Download PDF

Info

Publication number
CN113891895A
CN113891895A CN202080040317.1A CN202080040317A CN113891895A CN 113891895 A CN113891895 A CN 113891895A CN 202080040317 A CN202080040317 A CN 202080040317A CN 113891895 A CN113891895 A CN 113891895A
Authority
CN
China
Prior art keywords
analyte
seq
interest
binding agent
sequence identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080040317.1A
Other languages
English (en)
Chinese (zh)
Inventor
T·柯克兰
M·达特
Z·曾
T·史密斯
K·伍德
T·马赫莱特
E·约斯特
V·金凯德
H·王
W·周
L·英赛尔
M·霍尔
R·赫斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of CN113891895A publication Critical patent/CN113891895A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/103—Nucleic acid detection characterized by the use of physical, structural and functional properties luminescence

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
CN202080040317.1A 2019-04-10 2020-04-10 用于使用生物发光检测分析物的组合物和方法 Pending CN113891895A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962832052P 2019-04-10 2019-04-10
US62/832,052 2019-04-10
PCT/US2020/027711 WO2020210658A1 (en) 2019-04-10 2020-04-10 Compositions and methods for analyte detection using bioluminescence

Publications (1)

Publication Number Publication Date
CN113891895A true CN113891895A (zh) 2022-01-04

Family

ID=72751365

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080040317.1A Pending CN113891895A (zh) 2019-04-10 2020-04-10 用于使用生物发光检测分析物的组合物和方法

Country Status (11)

Country Link
US (2) US20200386748A1 (enExample)
EP (1) EP3953374A4 (enExample)
JP (2) JP7645812B2 (enExample)
KR (1) KR20220007058A (enExample)
CN (1) CN113891895A (enExample)
AU (1) AU2020272037B2 (enExample)
BR (1) BR112021020354A2 (enExample)
CA (1) CA3135195A1 (enExample)
IL (1) IL287261A (enExample)
SG (1) SG11202110773RA (enExample)
WO (1) WO2020210658A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114231401A (zh) * 2022-02-21 2022-03-25 北京芯迈微生物技术有限公司 一种核酸检测试剂盒及检测方法
CN116218907A (zh) * 2023-02-20 2023-06-06 复旦大学附属中山医院 带有HiBiT新型报告基因的肠道病毒感染性克隆及其构建方法和应用
CN118033130A (zh) * 2024-01-19 2024-05-14 武汉科技大学 同时检测艾滋病、梅毒和丙肝的表面、微孔板、组件、方法及应用
CN118255903A (zh) * 2024-05-07 2024-06-28 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种检测非洲猪瘟病毒抗体的融合抗原、制备方法及检测试剂盒
CN118344492A (zh) * 2024-05-07 2024-07-16 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种纳米荧光素酶融合抗原在非洲猪瘟病毒抗体检测中的应用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020392245A1 (en) 2019-11-27 2022-06-23 Promega Corporation Multipartite luciferase peptides and polypeptides
US20220396830A1 (en) * 2021-05-13 2022-12-15 Promega Corporation Bioluminescent detection of dna synthesis
WO2023028175A1 (en) * 2021-08-24 2023-03-02 Kaya17 Inc. System and method for detecting presence of a target bioparticle in a sample via a vertical flow assay
CN113786873B (zh) * 2021-08-31 2022-09-23 广西横县张一元饮品有限公司 一种用于食品安全检测的试管
JPWO2023053586A1 (enExample) * 2021-09-29 2023-04-06
WO2023200703A1 (en) * 2022-04-15 2023-10-19 Siemens Healthcare Diagnostics Inc. Creatinine lateral flow assay devices and methods of production and use thereof
GB2619059A (en) * 2022-05-26 2023-11-29 Univ Leeds Innovations Ltd Split reporter complex
WO2024129040A1 (en) * 2022-12-16 2024-06-20 T.C Ankara Universitesi Rektorlugu A card test for the hallucinogenic psilocybin molecule that allows the diagnosis of toxic mushrooms and mushroom toxicities
WO2024216135A1 (en) * 2023-04-12 2024-10-17 Promega Corporation Poloxamer-stabilized reagents
WO2025024530A1 (en) * 2023-07-25 2025-01-30 The General Hospital Corporation Aldehyde binding optical imaging probes methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140194325A1 (en) * 2012-12-12 2014-07-10 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US20140348747A1 (en) * 2013-03-15 2014-11-27 Promega Corporation Activation of bioluminescence by structural complementation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423290A (en) * 1966-08-03 1969-01-21 Nasa Lyophilized reaction mixtures
US6045254A (en) * 1996-12-26 2000-04-04 M.L.I.S. Projects Ltd. Container having two or more compartments
US7118878B1 (en) * 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
EP2325328B1 (en) * 2002-12-23 2014-02-12 Promega Corporation Improved luciferase-based assays
US7829347B2 (en) * 2005-08-31 2010-11-09 Kimberly-Clark Worldwide, Inc. Diagnostic test kits with improved detection accuracy
CA2659773A1 (en) * 2006-02-21 2007-08-30 Nanogen, Inc. Methods and compositions for analyte detection
CA3174484A1 (en) 2012-12-12 2014-06-19 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
JP6814132B2 (ja) * 2014-09-12 2021-01-13 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 内部タンパク質タグ
EP4455668A3 (en) * 2015-02-05 2025-02-19 Promega Corporation Luciferase-based thermal shift assays
US20170328896A1 (en) * 2016-02-19 2017-11-16 Insight Instruments, Inc. Assay systems for point of care detection of ocular analytes
US10634680B2 (en) * 2016-04-26 2020-04-28 University Of Utah Research Foundation Target-binding activated split reporter systems for analyte detection and related components and methods
US11327072B2 (en) 2017-02-09 2022-05-10 Promega Corporation Analyte detection immunoassay
JP6990369B2 (ja) * 2017-05-19 2022-02-03 国立大学法人 熊本大学 遺伝性腎疾患アルポート症候群治療薬に係る評価系

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140194325A1 (en) * 2012-12-12 2014-07-10 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US20140348747A1 (en) * 2013-03-15 2014-11-27 Promega Corporation Activation of bioluminescence by structural complementation

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANDREW S. DIXON ET AL: "NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells", ACS CHEMICAL BIOLOGY, vol. 11, no. 2, pages 400 - 408, XP055715353, DOI: 10.1021/acschembio.5b00753 *
KENTARO OH-HASHI ET AL: "Application of a novel HiBiT peptide tag for monitoring ATF4 protein expression in Neuro2a cells", BIOCHEMISTRY AND BIOPHYSICS REPORTS, vol. 12, pages 40 - 45, XP055607272, DOI: 10.1016/j.bbrep.2017.08.002 *
LIN XUE ET AL: "Bioluminescent Antibodies for Point-of-Care Diagnostics", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 56, no. 25, pages 7112 - 7116, XP055527910, DOI: 10.1002/anie.201702403 *
SCHWINN MARIE K ET AL: "Antibody-free detection of cellular neddylation dynamics of Cullin1", ANALYTICAL BIOCHEMISTRY, vol. 555, pages 67 - 72, XP085418421, DOI: 10.1016/j.ab.2018.05.002 *
YUKI OHMURO-MATSUYAMA ET AL: "Homogeneous Noncompetitive Luminescent lmmunodetection of Small Molecules by Ternary Protein Fragment Complementation", ANALYTICAL CHEMISTRY, vol. 90, no. 5, pages 3001 - 3004, XP055653694, DOI: 10.1021/acs.analchem.7b05140 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114231401A (zh) * 2022-02-21 2022-03-25 北京芯迈微生物技术有限公司 一种核酸检测试剂盒及检测方法
CN114231401B (zh) * 2022-02-21 2022-05-03 北京芯迈微生物技术有限公司 一种核酸检测试剂盒及检测方法
CN116218907A (zh) * 2023-02-20 2023-06-06 复旦大学附属中山医院 带有HiBiT新型报告基因的肠道病毒感染性克隆及其构建方法和应用
CN118033130A (zh) * 2024-01-19 2024-05-14 武汉科技大学 同时检测艾滋病、梅毒和丙肝的表面、微孔板、组件、方法及应用
CN118033130B (zh) * 2024-01-19 2024-07-30 武汉科技大学 同时检测艾滋病、梅毒和丙肝的表面、微孔板、组件、方法及应用
CN118255903A (zh) * 2024-05-07 2024-06-28 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种检测非洲猪瘟病毒抗体的融合抗原、制备方法及检测试剂盒
CN118344492A (zh) * 2024-05-07 2024-07-16 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种纳米荧光素酶融合抗原在非洲猪瘟病毒抗体检测中的应用
CN118255903B (zh) * 2024-05-07 2025-03-11 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 一种检测非洲猪瘟病毒抗体的融合抗原、制备方法及检测试剂盒

Also Published As

Publication number Publication date
JP2025133108A (ja) 2025-09-10
KR20220007058A (ko) 2022-01-18
SG11202110773RA (en) 2021-10-28
JP7645812B2 (ja) 2025-03-14
US20200386748A1 (en) 2020-12-10
AU2020272037A1 (en) 2021-12-02
IL287261A (en) 2021-12-01
EP3953374A4 (en) 2023-06-07
AU2020272037B2 (en) 2025-11-27
CA3135195A1 (en) 2020-10-15
EP3953374A1 (en) 2022-02-16
BR112021020354A2 (pt) 2021-12-14
US20250264464A1 (en) 2025-08-21
JP2022526013A (ja) 2022-05-20
WO2020210658A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
CN113891895A (zh) 用于使用生物发光检测分析物的组合物和方法
Söderberg et al. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay
US6511809B2 (en) Method for the detection of an analyte by means of a nucleic acid reporter
JP6070769B2 (ja) 蛍光標識抗体可変領域含有ポリペプチド複合体を用いた蛍光免疫測定キット
JP5841525B2 (ja) 蛍光アッセイ法
EP3807419A2 (en) Multipartite luciferase
JP2014156428A (ja) 抗体結合タンパク質
WO2015039423A1 (zh) 生物标记物的保存液、试剂和方法
JP2008518605A (ja) 同種の分析物検出
JP2009543084A (ja) 免疫抑制薬に関する均一系二重受容体凝集アッセイ
AU2016378819C1 (en) Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins
EP3111218B1 (en) Protein l based bioassay method for determining presence of soluble antibodies in a sample and kit therefor
KR20220121816A (ko) 다분할 루시퍼라제 펩타이드 및 폴리펩타이드
Wolf et al. Strategies for site‐specific labeling of receptor proteins on the surfaces of living cells by using genetically encoded peptide tags
Rousserie et al. Detection of carcinoembryonic antigen using single-domain or full-size antibodies stained with quantum dot conjugates
Fryer et al. Gigavalent display of proteins on monodisperse polyacrylamide hydrogels as a versatile modular platform for functional assays and protein engineering
JP2008520963A (ja) サンプル中の分析物を検出する方法
US8846869B2 (en) Mutant protein capable of binding specifically and quickly to troponin I derived from human myocardium
JP2014531206A (ja) 熱安定性アッセイ試薬
Sapsford et al. Detection of HIV-1 specific monoclonal antibodies using enhancement of dye-labeled antigenic peptides
Rhiel et al. Applications of Antibodies in Therapy, Diagnosis, and Science
RU2478970C1 (ru) Способ иммунофлуоресцентного определения протективного антигена возбудителя сибирской язвы
TWI553122B (zh) 用於分子與蛋白質基於螢光之定量偵測的方法與系統
US20100317032A1 (en) Method for detecting antigen and antigen detection device
CN120898132A (zh) 测定系统

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination